Zachary Smith

home / authors / zachary-smith

Assistant Director, Data Sciences and Analytics, with Tufts Center for the Study of Drug Development (Tufts CSDD)

Articles

Benchmarking the Investigative Site Qualification Process

Benchmarking the Investigative Site Qualification Process

Beth Harper, MBA ;Zachary Smith;Ruby Madison Ford;Ken Getz, MBA
February 10th 2025

Insights identify opportunities to optimize sponsor, CRO, and site collaborations.

© peshkova - © peshkova - stock.adobe.com.

Outsourcing Model Usage and its Relationship to Clinical Trial Performance

Mary Jo Lamberti, PhD;Zachary Smith;Maria DiPietro;John Barry;Ken Getz, MBA
October 12th 2023

Pilot study seeks to validate new and more granular outsourcing model classifications in differentiating performance across custom contract-service approaches.

Site Logo

The Impact of Decentralized and Hybrid Trials on Sponsor and CRO Collaborations

Mary Jo Lamberti, PhD;Zachary Smith;Abigail Dirks;Tina Caruana;Trinette Mitchell;Ken Getz, MBA
July 27th 2022

Tufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.

Characterizing Clinical Data Management Challenges and Their Impact

Characterizing Clinical Data Management Challenges and Their Impact

Beth Harper, MBA ;Zachary Smith;Jane Snowdon;Robert DiCicco;Rezzan Hekmat;Ken Getz, MBA
February 12th 2021

2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.

Latest Updated Articles

Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Published: February 13th 2025 | Updated: March 4th 2025
Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Accelerate Inclusive Enrollment and Delivery with Lightship
Published: February 19th 2025 | Updated: February 26th 2025
Accelerate Inclusive Enrollment and Delivery with Lightship
How Vaccine Trials Could be Affected by Potential Policy Changes
Published: May 8th 2025 | Updated: May 21st 2025
How Vaccine Trials Could be Affected by Potential Policy Changes
Published: February 3rd 2025 | Updated: May 21st 2025
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
Published: February 3rd 2025 | Updated: May 21st 2025
Data-Driven Insights can Optimize Clinical Trial Site Selection
Published: February 3rd 2025 | Updated: May 21st 2025
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation
© 2025 MJH Life Sciences

All rights reserved.